Identified Barriers to Implementing Xpert TB Testing in Studies in Low- and Middle-Income Countries
| Barriers | India | Mongolia | Mozambique | Nepal | Nigeria | Pakistan | Swaziland | Uganda | Vietnam |
|---|---|---|---|---|---|---|---|---|---|
| Patient-level factors | |||||||||
| Distance to testing sites29,33,35 | X | X | X | ||||||
| Cost of testing in private health clinics35 | X | ||||||||
| Human resources | |||||||||
| Inadequate/inconsistent staff training on testing processes/guidelines, and/or limited awareness of availability26,28–30,32,34,35 | X | X | X | X | X | X | X | ||
| Low self-efficacy and confidence that Xpert improves outcomes15 | X | ||||||||
| Workload capacity in laboratories15,30 | X | X | |||||||
| High staff turnover15,31,32 | X | X | X | ||||||
| Initial struggle with English software (since rectified)26 | X | ||||||||
| Material resources | |||||||||
| Inadequate power supply15,26,27,31,33,35 | X | X | X | X | X | X | |||
| Poorly equipped labs (e.g., limited space for patient assessment; no ventilation, workbench, air conditioning, and/or refrigerator)15,26,34 | X | X | X | ||||||
| Inappropriate storage of cartridges31 | X | ||||||||
| Service implementation | |||||||||
| Geographically dispersed TB laboratories35 | X | ||||||||
| Transportation of sputum samples (e.g., inconsistent/delays in availability of deliveries; improper packaging/temperature control during transport)15,32,34,35 | X | X | X | X | |||||
| Inability to track/follow up with patients testing positive15 | X | ||||||||
| Determining an appropriate testing algorithm26 | X | ||||||||
| Failure to identify eligible cases for screening30,32 | X | X | |||||||
| Limitations to accessing updated and clear standard operating procedures/internal audits27,32 | X | X | |||||||
| Poor quality samples collected27,29,30,32 | X | X | X | X | |||||
| Service coordination | |||||||||
| Supply chain for procurement of cartridges, reagents, and/or medicines resulting in lack of supplies15,26,30,32–35 | X | X | X | X | X | X | X | ||
| Lack of referral pathways/communication between staff and health centers (e.g., referral pathways and transfer of results)27–30,32–35 | X | X | X | X | X | X | X | X | |
| Insufficient oversight from national body/remote monitoring15,26 | X | X | |||||||
| Delays in notification of results15,26,28–30,34 | X | X | X | X | X | ||||
| Limited ability to track positive cases and confirm treatment26,28,35 | X | X | X | ||||||
| Technical operations | |||||||||
| Xpert maintenance (e.g., frequency of maintenance not always implemented as required; poor understanding of routine maintenance in dusty, non-temperature-controlled labs)26–28,31,33,35 | X | X | X | X | X | X | |||
| Failure of calibration and required replacement26 | X | ||||||||
| Lack of timely replacement of damaged modules33 | X | ||||||||
| Module malfunction28,31 | X | X | |||||||
| Limited internet connectivity26,31 | X | X | |||||||
| Local repair options limited30 | X |